The Role of COVID-19 in Antibiotic Resistance in Pediatric Population

There is data on the irrational use of antimicrobial drugs in pediatric population during the COVID-19 pandemic. This could lead to potential development of antibiotic resistance and increased morbidity and mortality among this vulnerable population group. The aim of this review is to study the role...

Full description

Saved in:
Bibliographic Details
Main Authors: Kirill O. Kuznetsov, Laysan R. Tukbaeva, Valeriya V. Kazakova, Kamilla R. Mirzoeva, Ekaterina A. Bogomolova, Adelina I. Salakhutdinova, Darya Yu. Ponomareva, Aigul R. Garipova, Marina S.-M. Mutsolgova, Arslan G. Galimkhanov, Marsel I. Sakhibgareev, Elina R. Guzhvieva
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2023-01-01
Series:Педиатрическая фармакология
Subjects:
Online Access:https://www.pedpharma.ru/jour/article/view/2233
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695819375050752
author Kirill O. Kuznetsov
Laysan R. Tukbaeva
Valeriya V. Kazakova
Kamilla R. Mirzoeva
Ekaterina A. Bogomolova
Adelina I. Salakhutdinova
Darya Yu. Ponomareva
Aigul R. Garipova
Marina S.-M. Mutsolgova
Arslan G. Galimkhanov
Marsel I. Sakhibgareev
Elina R. Guzhvieva
author_facet Kirill O. Kuznetsov
Laysan R. Tukbaeva
Valeriya V. Kazakova
Kamilla R. Mirzoeva
Ekaterina A. Bogomolova
Adelina I. Salakhutdinova
Darya Yu. Ponomareva
Aigul R. Garipova
Marina S.-M. Mutsolgova
Arslan G. Galimkhanov
Marsel I. Sakhibgareev
Elina R. Guzhvieva
author_sort Kirill O. Kuznetsov
collection DOAJ
description There is data on the irrational use of antimicrobial drugs in pediatric population during the COVID-19 pandemic. This could lead to potential development of antibiotic resistance and increased morbidity and mortality among this vulnerable population group. The aim of this review is to study the role of COVID-19 in antimicrobial drugs administration and antibiotic resistance development, as well as to determine a set of measures for its prevention. Recent studies results have shown that COVID-19 pandemic had both direct and indirect impact on antibiotic resistance development in pediatric population. The COVID-19 outbreak has revealed weaknesses in health systems around the world. Antibiotics administration in patients with coronavirus infection during this period exceeded the number of cases with bacterial co-infection or other diseases. Thus, it indicates irrational antibiotic treatment. There were cases of inappropriate antibiotics administration during the crisis caused by the COVID-19 pandemic even in regions with long-term rational antibiotic treatment programs. One of the most viable methods to combat antibiotic resistance is to improve approaches in health care and to increase preparedness to infectious outbreaks. Increasing clinical competence of medical workers, accessibility of medical facilities, permanent supply of high-quality and cheap antibiotics, vaccines, reducing COVID-19 testing time, and adequate administration of antibacterial agents are the measures that can prevent diseases caused by drug resistance. All stakeholders (health authorities, regulating authorities, politicians, scientific community, pharmaceutical companies) have to collaborate and achieve results to implement all the mentioned above protection measures.
format Article
id doaj-art-88a18387f33b4df9a4df9f39ff92e8da
institution DOAJ
issn 1727-5776
2500-3089
language Russian
publishDate 2023-01-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-88a18387f33b4df9a4df9f39ff92e8da2025-08-20T03:19:39ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892023-01-0119650351310.15690/pf.v19i6.24651947The Role of COVID-19 in Antibiotic Resistance in Pediatric PopulationKirill O. Kuznetsov0Laysan R. Tukbaeva1Valeriya V. Kazakova2Kamilla R. Mirzoeva3Ekaterina A. Bogomolova4Adelina I. Salakhutdinova5Darya Yu. Ponomareva6Aigul R. Garipova7Marina S.-M. Mutsolgova8Arslan G. Galimkhanov9Marsel I. Sakhibgareev10Elina R. Guzhvieva11Bashkir State Medical UniversityBashkir State Medical UniversitySaint Petersburg State Pediatric Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityThere is data on the irrational use of antimicrobial drugs in pediatric population during the COVID-19 pandemic. This could lead to potential development of antibiotic resistance and increased morbidity and mortality among this vulnerable population group. The aim of this review is to study the role of COVID-19 in antimicrobial drugs administration and antibiotic resistance development, as well as to determine a set of measures for its prevention. Recent studies results have shown that COVID-19 pandemic had both direct and indirect impact on antibiotic resistance development in pediatric population. The COVID-19 outbreak has revealed weaknesses in health systems around the world. Antibiotics administration in patients with coronavirus infection during this period exceeded the number of cases with bacterial co-infection or other diseases. Thus, it indicates irrational antibiotic treatment. There were cases of inappropriate antibiotics administration during the crisis caused by the COVID-19 pandemic even in regions with long-term rational antibiotic treatment programs. One of the most viable methods to combat antibiotic resistance is to improve approaches in health care and to increase preparedness to infectious outbreaks. Increasing clinical competence of medical workers, accessibility of medical facilities, permanent supply of high-quality and cheap antibiotics, vaccines, reducing COVID-19 testing time, and adequate administration of antibacterial agents are the measures that can prevent diseases caused by drug resistance. All stakeholders (health authorities, regulating authorities, politicians, scientific community, pharmaceutical companies) have to collaborate and achieve results to implement all the mentioned above protection measures.https://www.pedpharma.ru/jour/article/view/2233antibiotic resistancecovid-19antibiotic treatmentguidelineschildren
spellingShingle Kirill O. Kuznetsov
Laysan R. Tukbaeva
Valeriya V. Kazakova
Kamilla R. Mirzoeva
Ekaterina A. Bogomolova
Adelina I. Salakhutdinova
Darya Yu. Ponomareva
Aigul R. Garipova
Marina S.-M. Mutsolgova
Arslan G. Galimkhanov
Marsel I. Sakhibgareev
Elina R. Guzhvieva
The Role of COVID-19 in Antibiotic Resistance in Pediatric Population
Педиатрическая фармакология
antibiotic resistance
covid-19
antibiotic treatment
guidelines
children
title The Role of COVID-19 in Antibiotic Resistance in Pediatric Population
title_full The Role of COVID-19 in Antibiotic Resistance in Pediatric Population
title_fullStr The Role of COVID-19 in Antibiotic Resistance in Pediatric Population
title_full_unstemmed The Role of COVID-19 in Antibiotic Resistance in Pediatric Population
title_short The Role of COVID-19 in Antibiotic Resistance in Pediatric Population
title_sort role of covid 19 in antibiotic resistance in pediatric population
topic antibiotic resistance
covid-19
antibiotic treatment
guidelines
children
url https://www.pedpharma.ru/jour/article/view/2233
work_keys_str_mv AT kirillokuznetsov theroleofcovid19inantibioticresistanceinpediatricpopulation
AT laysanrtukbaeva theroleofcovid19inantibioticresistanceinpediatricpopulation
AT valeriyavkazakova theroleofcovid19inantibioticresistanceinpediatricpopulation
AT kamillarmirzoeva theroleofcovid19inantibioticresistanceinpediatricpopulation
AT ekaterinaabogomolova theroleofcovid19inantibioticresistanceinpediatricpopulation
AT adelinaisalakhutdinova theroleofcovid19inantibioticresistanceinpediatricpopulation
AT daryayuponomareva theroleofcovid19inantibioticresistanceinpediatricpopulation
AT aigulrgaripova theroleofcovid19inantibioticresistanceinpediatricpopulation
AT marinasmmutsolgova theroleofcovid19inantibioticresistanceinpediatricpopulation
AT arslanggalimkhanov theroleofcovid19inantibioticresistanceinpediatricpopulation
AT marselisakhibgareev theroleofcovid19inantibioticresistanceinpediatricpopulation
AT elinarguzhvieva theroleofcovid19inantibioticresistanceinpediatricpopulation
AT kirillokuznetsov roleofcovid19inantibioticresistanceinpediatricpopulation
AT laysanrtukbaeva roleofcovid19inantibioticresistanceinpediatricpopulation
AT valeriyavkazakova roleofcovid19inantibioticresistanceinpediatricpopulation
AT kamillarmirzoeva roleofcovid19inantibioticresistanceinpediatricpopulation
AT ekaterinaabogomolova roleofcovid19inantibioticresistanceinpediatricpopulation
AT adelinaisalakhutdinova roleofcovid19inantibioticresistanceinpediatricpopulation
AT daryayuponomareva roleofcovid19inantibioticresistanceinpediatricpopulation
AT aigulrgaripova roleofcovid19inantibioticresistanceinpediatricpopulation
AT marinasmmutsolgova roleofcovid19inantibioticresistanceinpediatricpopulation
AT arslanggalimkhanov roleofcovid19inantibioticresistanceinpediatricpopulation
AT marselisakhibgareev roleofcovid19inantibioticresistanceinpediatricpopulation
AT elinarguzhvieva roleofcovid19inantibioticresistanceinpediatricpopulation